Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Nevro Corp. (NVRO)

139.66   0.26 (0.19%) 02-14 16:02
Open: 140.06 Pre. Close: 139.4
High: 140.42 Low: 137.375
Volume: 164,939 Market Cap: 4304M
Nevro Corp develops and sells medical devices mainly in the United States. Its main product is the Senza system which is intended to relieve leg and spinal cord pain with the application of the HF10 therapy.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 140.579 - 141.137 141.137 - 141.618
Low: 135.837 - 136.526 136.526 - 137.119
Close: 138.469 - 139.594 139.594 - 140.564

Technical analysis

as of: 2020-02-14 4:31:14 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 164.35     One year: 191.96
Support: Support1: 122.46    Support2: 111.18
Resistance: Resistance1: 140.71    Resistance2: 164.35
Pivot: 137.43
Moving Average: MA(5): 139.40     MA(20): 134.01
MA(100): 107.52     MA(250): 81.93
MACD: MACD(12,26): 5.40     Signal(9): 5.57
Stochastic oscillator: %K(14,3): 94.63     %D(3): 94.60
RSI: RSI(14): 68.45
52-week: High: 140.71  Low: 41.25  Change(%): 195.3
Average Vol(K): 3-Month: 38356  10-Days: 26133

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVRO has closed below upper band by 25.3%. Bollinger Bands are 41.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to NVRO's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

US company provided kickbacks to doctors in Switzerland
US medical device company Nevro promised to pay doctors in Switzerland if they used the company’s spinal cord stimulation system.

Nevro : Annual Statement of Changes in Beneficial Ownership | MarketScreener
FORM 5 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1. [… | February 15, 2020

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 31.01
Shares Float (M) 28.17
% Held by Insiders 2.49
% Held by Institutions 111.64
Shares Short (K) 3120
Shares Short P. Month (K)

Stock Financials

EPS -3.260
Book Value (p.s.) 6.390
PEG Ratio -1.52
Profit Margin -25.94
Operating Margin -24.33
Return on Assets (ttm) -13.0
Return on Equity (ttm) -45.0
Qtrly Rev. Growth 4.7
Gross Profit (p.s.) 8.814
Sales Per Share
EBITDA (p.s.) -2.872
Qtrly Earnings Growth
Operating Cash Flow (M) -31.75
Levered Free Cash Flow (M) -1.89

Stock Valuations

P/E -42.84
P/E Growth Ratio
P/BV 21.86
P/S 11.11
P/CF -136.40

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-11-05
Last Split Ratio 0.042
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.